Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 71614 | 64.43 |
09:34 ET | 64502 | 63.83 |
09:36 ET | 64544 | 63.73 |
09:38 ET | 23147 | 64.07 |
09:39 ET | 32605 | 64.17 |
09:41 ET | 37462 | 64.24 |
09:43 ET | 20669 | 64.18 |
09:45 ET | 32551 | 64.4 |
09:48 ET | 50648 | 64.52 |
09:50 ET | 16259 | 64.59 |
09:52 ET | 28607 | 64.625 |
09:54 ET | 14471 | 64.71 |
09:56 ET | 26985 | 64.68 |
09:57 ET | 22880 | 64.44 |
09:59 ET | 16473 | 64.31 |
10:01 ET | 23087 | 64.6462 |
10:03 ET | 12831 | 64.445 |
10:06 ET | 10501 | 64.3831 |
10:08 ET | 4610 | 64.41 |
10:10 ET | 23505 | 64.464 |
10:12 ET | 66639 | 65 |
10:14 ET | 21113 | 64.8 |
10:15 ET | 11651 | 64.77 |
10:17 ET | 9627 | 64.71 |
10:19 ET | 11656 | 64.68 |
10:21 ET | 17318 | 64.875 |
10:24 ET | 40337 | 64.82 |
10:26 ET | 9787 | 64.6601 |
10:28 ET | 21998 | 64.63 |
10:30 ET | 10515 | 64.455 |
10:32 ET | 18167 | 64.5972 |
10:33 ET | 13088 | 64.5673 |
10:35 ET | 5467 | 64.585 |
10:37 ET | 9386 | 64.5036 |
10:39 ET | 3655 | 64.5601 |
10:42 ET | 20477 | 64.62 |
10:44 ET | 9150 | 64.45 |
10:46 ET | 4067 | 64.44 |
10:48 ET | 10111 | 64.495 |
10:50 ET | 7166 | 64.24 |
10:51 ET | 11233 | 64.31 |
10:53 ET | 3584 | 64.19 |
10:55 ET | 14181 | 64.1 |
10:57 ET | 20631 | 64.0199 |
11:00 ET | 12899 | 63.88 |
11:02 ET | 14696 | 63.77 |
11:04 ET | 10006 | 63.8501 |
11:06 ET | 9689 | 63.88 |
11:08 ET | 6992 | 63.865 |
11:09 ET | 11077 | 64 |
11:11 ET | 4241 | 63.87 |
11:13 ET | 7033 | 63.83 |
11:15 ET | 3337 | 63.8156 |
11:18 ET | 6002 | 63.87 |
11:20 ET | 21371 | 63.805 |
11:22 ET | 13416 | 63.79 |
11:24 ET | 9287 | 63.8 |
11:26 ET | 4500 | 63.76 |
11:27 ET | 22489 | 63.58 |
11:29 ET | 21534 | 63.645 |
11:31 ET | 6666 | 63.675 |
11:33 ET | 4940 | 63.765 |
11:36 ET | 12811 | 63.79 |
11:38 ET | 5519 | 63.69 |
11:40 ET | 12644 | 63.64 |
11:42 ET | 35362 | 63.5 |
11:44 ET | 24656 | 63.42 |
11:45 ET | 7331 | 63.475 |
11:47 ET | 9377 | 63.63 |
11:49 ET | 8300 | 63.63 |
11:51 ET | 11385 | 63.725 |
11:54 ET | 18790 | 63.9 |
11:56 ET | 9483 | 63.925 |
11:58 ET | 7887 | 63.95 |
12:00 ET | 21873 | 63.86 |
12:02 ET | 12827 | 63.8001 |
12:03 ET | 5567 | 63.84 |
12:05 ET | 5552 | 63.87 |
12:07 ET | 5000 | 63.88 |
12:09 ET | 10167 | 63.89 |
12:12 ET | 2305 | 63.86 |
12:14 ET | 4756 | 63.8 |
12:16 ET | 18969 | 63.8002 |
12:18 ET | 8683 | 63.76 |
12:20 ET | 11830 | 63.93 |
12:21 ET | 25405 | 63.975 |
12:23 ET | 11174 | 64.025 |
12:25 ET | 19037 | 64.08 |
12:27 ET | 22067 | 64.0792 |
12:30 ET | 18062 | 64.14 |
12:32 ET | 10376 | 64.15 |
12:34 ET | 11423 | 64.1904 |
12:36 ET | 7312 | 64.26 |
12:38 ET | 5799 | 64.1701 |
12:39 ET | 8718 | 64.04 |
12:41 ET | 4000 | 63.955 |
12:43 ET | 4129 | 63.9 |
12:45 ET | 3954 | 63.92 |
12:48 ET | 4318 | 63.97 |
12:50 ET | 1820 | 63.92 |
12:52 ET | 4539 | 63.9 |
12:54 ET | 2507 | 63.86 |
12:56 ET | 6181 | 63.7523 |
12:57 ET | 27942 | 63.53 |
12:59 ET | 30547 | 63.65 |
01:01 ET | 8497 | 63.71 |
01:03 ET | 12682 | 63.8 |
01:06 ET | 3103 | 63.815 |
01:08 ET | 6151 | 63.71 |
01:10 ET | 2762 | 63.7 |
01:12 ET | 6628 | 63.725 |
01:14 ET | 6432 | 63.64 |
01:15 ET | 3789 | 63.6135 |
01:17 ET | 6222 | 63.5205 |
01:19 ET | 3657 | 63.61 |
01:21 ET | 14443 | 63.52 |
01:24 ET | 10209 | 63.4842 |
01:26 ET | 3639 | 63.495 |
01:28 ET | 5785 | 63.44 |
01:30 ET | 9913 | 63.51 |
01:32 ET | 10961 | 63.52 |
01:33 ET | 16990 | 63.485 |
01:35 ET | 3830 | 63.485 |
01:37 ET | 7809 | 63.42 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 24.5B | -4.1x | --- |
ICON PLC | 23.5B | 33.2x | +4.68% |
Biontech SE | 27.5B | -50.3x | --- |
Biogen Inc | 27.5B | 24.2x | -18.14% |
Grifols SA | 6.7B | 35.1x | --- |
Beigene Ltd | 22.6B | -41.9x | --- |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $24.5B |
---|---|
Revenue (TTM) | $5.1B |
Shares Outstanding | 384.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.67 |
EPS | $-15.37 |
Book Value | $36.27 |
P/E Ratio | -4.1x |
Price/Sales (TTM) | 4.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -91.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.